With coronavirus cases around the world now at over 63 million, scientists have been working around the clock to develop a vaccine.
Jabs from Pfizer, Moderna and AstraZeneca are undergoing Phase 3 clinical trials, and now it seems that Pfizer’s offering could be one step closer to launching.
Pfizer and BioNTech have applied to the European drugs regulator for conditional authorization of their COVID-19 vaccine, following similar steps in the United States and Britain, the companies said on Tuesday.
The application to the European Medicines Agency (EMA) comes after the companies applied for U.S. approval on Nov. 20, taking them a step closer to launching their vaccine.